Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results (Showing 1 to 16 of 16)As of 9-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
1-Feb-10Roth Capital Partners, Inc.Matt DolanICUI: ICU Medical 4Q09 Earnings Preview4$104 Stars  View Abstract
28-Jan-10Roth Capital Partners, Inc.Matt DolanVITA: KNSY Royalties Imply Roughly Inline 4Q09 Sales for VITA4$104 Stars  View Abstract
28-Jan-10Roth Capital Partners, Inc.Matt Dolan2010 EPS Looking More Like 2011; Boosting Estimates & Target; Reiterate Buy9$254 Stars  View Abstract
27-Jan-10Roth Capital Partners, Inc.Matt DolanVOLC: Sales Guidance Comes Out Early... Looks Solid; Reiterate Buy4$104 Stars  View Abstract
26-Jan-10Roth Capital Partners, Inc.Matt DolanQuick Take: Clinical Labs - Questions on Reimbursement in 20106$254 Stars  View Abstract
26-Jan-10Roth Capital Partners, Inc.Matt DolanAlign Technology 4Q09 Earnings Preview4$104 Stars  View Abstract
25-Jan-10Roth Capital Partners, Inc.Matt DolanMedafor Responds to CRY: Acquisition Seems More Probable Now; Maintain Buy4$104 Stars  View Abstract
25-Jan-10Roth Capital Partners, Inc.Matt Dolan4Q09 Medical Device Earnings Preview: Part 16$254 Stars  View Abstract
15-Jan-10Roth Capital Partners, Inc.Matt DolanOSTE Preannounces an Inline 4Q: Licensing Helps, New Products Starting Up; Hold6$254 Stars  View Abstract
14-Jan-10Roth Capital Partners, Inc.Matt DolanAlpine Reorg Drives Leverage; Increasingly Confident in 2010; Reiterate Buy7$254 Stars  View Abstract
12-Jan-10Roth Capital Partners, Inc.Matt DolanMedical Device Preannouncement Tally: Mostly Positive for 4Q09, 1H104$104 Stars  View Abstract
11-Jan-10Roth Capital Partners, Inc.Matt DolanStrong 4Q Beat on Improving Spending, Utilization & Japan; Reiterate Buy4$104 Stars  View Abstract
6-Jan-10Roth Capital Partners, Inc.Matt Dolan4Q 2009: Quarterly Medical Device Trading & Acquisition Valuation Update8$254 Stars  View Abstract
30-Dec-09Roth Capital Partners, Inc.Matt DolanSPNC: Federal Resolution in Time for Year-End; Back to Business in 20104$104 Stars  View Abstract
29-Dec-09Roth Capital Partners, Inc.Matt DolanCLRT: Updating Model for AGI Deal; Maintain Buy6$254 Stars  View Abstract
29-Dec-09Roth Capital Partners, Inc.Matt DolanModel & News Update: Good Growth Opportunities in 2010; Maintain Buy7$254 Stars  View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.